Sequent Scientific
SEQUENT · Pharma > Pharmaceuticals & Drugs · Chairman: Kamal K Sharma · MD: Manish Gupta · Listing date: March 11, 2016 · Employees: 1770 · Bangalore · http://www.sequent.in

Stock Price vs Company Growth
1d
3.4%
1w
11.8%
1m
10.1%
3m
27.9%
6m
22.0%
1y
19.5%
5y
16.5%
all
2.9%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec10Jun14Dec17Jun21Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

137 3.4%
135
210
Company Overview

Sales
1,511 Cr
Growth: 4.4%
Profit after Tax
11.6 Cr
Growth: -15.1%
Small Cap
3,420 Cr
P/E: 303.7x
Industry P/E: 29.7x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 1,511
Growth 4.4%
EBITDA 9.8%
P/S 2.3x
Dividend 0.0%
P/E 303.7x
Book Value ₹ 26.7
PEG Ratio 71.6x
ROE 1.8%
P/B 5.3x
Shareholding Pattern

Institutions
Infinity Holdings
5.91 %
Unit Trust Of India Investment Advisory Services Limited A/C Ascent India Fund Iii
3.35 %
Ashoka India Opportunities Fund
1.35 %
Sbi Healthcare Opportunities Fund
1.21 %
Mukul Mahavir Agrawal
1.05 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Jun21Sep21
Promoters
Ca Harbor Investments
53.02 %
Chayadeep Ventures Llp
0.27 %
Rajitha Gopalakrishnan
0.2 %
Sajitha Pillai
0.15 %
Vineetha Mohanakumar Pillai
0.12 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Jun21Sep21
Others
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Jun21Sep21
Increase    Decrease    No change
Company Profile Detailed

Sequent Scientific earlier known as P I Drugs & Pharmaceuticals is an integrated pharmaceutical company. Hon'ble High Court of Bombay approved the Scheme of Amalgamation of company with P I Drugs & Pharmaceuticals Ltd.
Investors (90)
Followers (7)